世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Multiple Myeloma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3954
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、多発性骨髄腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）、用途別市場規模（病院、クリニック、がん治療・リハビリテーションセンター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・多発性骨髄腫治療の市場動向
・企業の競争状況、市場シェア
・多発性骨髄腫治療の種類別市場規模（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）
・多発性骨髄腫治療の用途別市場規模（病院、クリニック、がん治療・リハビリテーションセンター）
・多発性骨髄腫治療の北米市場規模2016-2027（アメリカ、カナダ）
・多発性骨髄腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・多発性骨髄腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多発性骨髄腫治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・多発性骨髄腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Johnson & Johnson、Roche Holding、Sanofi、Eli Lilly、Novartis）
・結論

Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. Plasma cells helps to fight infections by making antibodies that recognize and attack germs. Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. These malignant plasma cells then produce abnormal proteins (m protein) which may cause tumors, damage the kidneys, and impair immune system function.
The global Multiple Myeloma market is anticipated to be mainly driven by increase in ageing population, rising obese population, increase in healthcare expenditure and increased penetration of novel cancer drugs. Some of the significant developments of this industry include upcoming new innovative products in the market, trend of combination therapies, and chance of new players.

Market Analysis and Insights: Global Multiple Myeloma Treatment Market
The global Multiple Myeloma Treatment market size is projected to reach US$ 55870 million by 2026, from US$ 27270 million in 2019, at a CAGR of 10.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multiple Myeloma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multiple Myeloma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multiple Myeloma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multiple Myeloma Treatment market.

Global Multiple Myeloma Treatment Scope and Market Size
Multiple Myeloma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Myeloma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Proteasome Inhibitors
Immunomodulatory Agents (IMiDs)
Histone Deacetylase (HDAC) Inhibitors
Immunotherapy
Cytotoxic Chemotherapy

Segment by Application
Hospitals
Clinics
Cancer Treatment and Rehabilitation Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Roche Holding
Sanofi
Eli Lilly
Novartis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Myeloma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Proteasome Inhibitors
1.2.3 Immunomodulatory Agents (IMiDs)
1.2.4 Histone Deacetylase (HDAC) Inhibitors
1.2.5 Immunotherapy
1.2.6 Cytotoxic Chemotherapy
1.3 Market by Application
1.3.1 Global Multiple Myeloma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Treatment and Rehabilitation Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Multiple Myeloma Treatment Market Perspective (2016-2027)
2.2 Multiple Myeloma Treatment Growth Trends by Regions
2.2.1 Multiple Myeloma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Multiple Myeloma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Multiple Myeloma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Multiple Myeloma Treatment Industry Dynamic
2.3.1 Multiple Myeloma Treatment Market Trends
2.3.2 Multiple Myeloma Treatment Market Drivers
2.3.3 Multiple Myeloma Treatment Market Challenges
2.3.4 Multiple Myeloma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Multiple Myeloma Treatment Players by Revenue
3.1.1 Global Top Multiple Myeloma Treatment Players by Revenue (2016-2021)
3.1.2 Global Multiple Myeloma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Multiple Myeloma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Multiple Myeloma Treatment Revenue
3.4 Global Multiple Myeloma Treatment Market Concentration Ratio
3.4.1 Global Multiple Myeloma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Treatment Revenue in 2020
3.5 Multiple Myeloma Treatment Key Players Head office and Area Served
3.6 Key Players Multiple Myeloma Treatment Product Solution and Service
3.7 Date of Enter into Multiple Myeloma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Multiple Myeloma Treatment Breakdown Data by Type
4.1 Global Multiple Myeloma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Multiple Myeloma Treatment Forecasted Market Size by Type (2022-2027)

5 Multiple Myeloma Treatment Breakdown Data by Application
5.1 Global Multiple Myeloma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Multiple Myeloma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Multiple Myeloma Treatment Market Size (2016-2027)
6.2 North America Multiple Myeloma Treatment Market Size by Type
6.2.1 North America Multiple Myeloma Treatment Market Size by Type (2016-2021)
6.2.2 North America Multiple Myeloma Treatment Market Size by Type (2022-2027)
6.2.3 North America Multiple Myeloma Treatment Market Size by Type (2016-2027)
6.3 North America Multiple Myeloma Treatment Market Size by Application
6.3.1 North America Multiple Myeloma Treatment Market Size by Application (2016-2021)
6.3.2 North America Multiple Myeloma Treatment Market Size by Application (2022-2027)
6.3.3 North America Multiple Myeloma Treatment Market Size by Application (2016-2027)
6.4 North America Multiple Myeloma Treatment Market Size by Country
6.4.1 North America Multiple Myeloma Treatment Market Size by Country (2016-2021)
6.4.2 North America Multiple Myeloma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Multiple Myeloma Treatment Market Size (2016-2027)
7.2 Europe Multiple Myeloma Treatment Market Size by Type
7.2.1 Europe Multiple Myeloma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Multiple Myeloma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Multiple Myeloma Treatment Market Size by Type (2016-2027)
7.3 Europe Multiple Myeloma Treatment Market Size by Application
7.3.1 Europe Multiple Myeloma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Multiple Myeloma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Multiple Myeloma Treatment Market Size by Application (2016-2027)
7.4 Europe Multiple Myeloma Treatment Market Size by Country
7.4.1 Europe Multiple Myeloma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Multiple Myeloma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Multiple Myeloma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Multiple Myeloma Treatment Market Size by Type
8.2.1 Asia-Pacific Multiple Myeloma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Multiple Myeloma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Multiple Myeloma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Multiple Myeloma Treatment Market Size by Application
8.3.1 Asia-Pacific Multiple Myeloma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Multiple Myeloma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Multiple Myeloma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Multiple Myeloma Treatment Market Size by Region
8.4.1 Asia-Pacific Multiple Myeloma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Multiple Myeloma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Multiple Myeloma Treatment Market Size (2016-2027)
9.2 Latin America Multiple Myeloma Treatment Market Size by Type
9.2.1 Latin America Multiple Myeloma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Multiple Myeloma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Multiple Myeloma Treatment Market Size by Type (2016-2027)
9.3 Latin America Multiple Myeloma Treatment Market Size by Application
9.3.1 Latin America Multiple Myeloma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Multiple Myeloma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Multiple Myeloma Treatment Market Size by Application (2016-2027)
9.4 Latin America Multiple Myeloma Treatment Market Size by Country
9.4.1 Latin America Multiple Myeloma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Multiple Myeloma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Multiple Myeloma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Multiple Myeloma Treatment Market Size by Type
10.2.1 Middle East & Africa Multiple Myeloma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Multiple Myeloma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Multiple Myeloma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Multiple Myeloma Treatment Market Size by Application
10.3.1 Middle East & Africa Multiple Myeloma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Multiple Myeloma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Multiple Myeloma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Multiple Myeloma Treatment Market Size by Country
10.4.1 Middle East & Africa Multiple Myeloma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Multiple Myeloma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Multiple Myeloma Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Multiple Myeloma Treatment Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Roche Holding
11.2.1 Roche Holding Company Details
11.2.2 Roche Holding Business Overview
11.2.3 Roche Holding Multiple Myeloma Treatment Introduction
11.2.4 Roche Holding Revenue in Multiple Myeloma Treatment Business (2016-2021)
11.2.5 Roche Holding Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Multiple Myeloma Treatment Introduction
11.3.4 Sanofi Revenue in Multiple Myeloma Treatment Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Multiple Myeloma Treatment Introduction
11.4.4 Eli Lilly Revenue in Multiple Myeloma Treatment Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Multiple Myeloma Treatment Introduction
11.5.4 Novartis Revenue in Multiple Myeloma Treatment Business (2016-2021)
11.5.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Multiple Myeloma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Proteasome Inhibitors
Table 3. Key Players of Immunomodulatory Agents (IMiDs)
Table 4. Key Players of Histone Deacetylase (HDAC) Inhibitors
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Cytotoxic Chemotherapy
Table 7. Global Multiple Myeloma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Multiple Myeloma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Multiple Myeloma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Multiple Myeloma Treatment Market Share by Regions (2016-2021)
Table 11. Global Multiple Myeloma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Multiple Myeloma Treatment Market Share by Regions (2022-2027)
Table 13. Multiple Myeloma Treatment Market Trends
Table 14. Multiple Myeloma Treatment Market Drivers
Table 15. Multiple Myeloma Treatment Market Challenges
Table 16. Multiple Myeloma Treatment Market Restraints
Table 17. Global Multiple Myeloma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Multiple Myeloma Treatment Market Share by Players (2016-2021)
Table 19. Global Top Multiple Myeloma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Myeloma Treatment as of 2020)
Table 20. Ranking of Global Top Multiple Myeloma Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Multiple Myeloma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Multiple Myeloma Treatment Product Solution and Service
Table 24. Date of Enter into Multiple Myeloma Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiple Myeloma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Multiple Myeloma Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Multiple Myeloma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Multiple Myeloma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Multiple Myeloma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Multiple Myeloma Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Multiple Myeloma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Multiple Myeloma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Multiple Myeloma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Multiple Myeloma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Multiple Myeloma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Multiple Myeloma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Multiple Myeloma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Multiple Myeloma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Multiple Myeloma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Multiple Myeloma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Multiple Myeloma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Multiple Myeloma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Multiple Myeloma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Multiple Myeloma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Multiple Myeloma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Multiple Myeloma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Multiple Myeloma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Multiple Myeloma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Multiple Myeloma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Multiple Myeloma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Multiple Myeloma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Multiple Myeloma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Multiple Myeloma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Multiple Myeloma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Multiple Myeloma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Multiple Myeloma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Multiple Myeloma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Multiple Myeloma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Multiple Myeloma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Multiple Myeloma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Multiple Myeloma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Multiple Myeloma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Johnson & Johnson Company Details
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Multiple Myeloma Treatment Product
Table 67. Johnson & Johnson Revenue in Multiple Myeloma Treatment Business (2016-2021) & (US$ Million)
Table 68. Johnson & Johnson Recent Development
Table 69. Roche Holding Company Details
Table 70. Roche Holding Business Overview
Table 71. Roche Holding Multiple Myeloma Treatment Product
Table 72. Roche Holding Revenue in Multiple Myeloma Treatment Business (2016-2021) & (US$ Million)
Table 73. Roche Holding Recent Development
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Multiple Myeloma Treatment Product
Table 77. Sanofi Revenue in Multiple Myeloma Treatment Business (2016-2021) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Eli Lilly Company Details
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Multiple Myeloma Treatment Product
Table 82. Eli Lilly Revenue in Multiple Myeloma Treatment Business (2016-2021) & (US$ Million)
Table 83. Eli Lilly Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Multiple Myeloma Treatment Product
Table 87. Novartis Revenue in Multiple Myeloma Treatment Business (2016-2021) & (US$ Million)
Table 88. Novartis Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Myeloma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Proteasome Inhibitors Features
Figure 3. Immunomodulatory Agents (IMiDs) Features
Figure 4. Histone Deacetylase (HDAC) Inhibitors Features
Figure 5. Immunotherapy Features
Figure 6. Cytotoxic Chemotherapy Features
Figure 7. Global Multiple Myeloma Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Cancer Treatment and Rehabilitation Centers Case Studies
Figure 11. Multiple Myeloma Treatment Report Years Considered
Figure 12. Global Multiple Myeloma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Multiple Myeloma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Multiple Myeloma Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Multiple Myeloma Treatment Market Share by Regions (2022-2027)
Figure 16. Global Multiple Myeloma Treatment Market Share by Players in 2020
Figure 17. Global Top Multiple Myeloma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Myeloma Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Multiple Myeloma Treatment Revenue in 2020
Figure 19. Global Multiple Myeloma Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Multiple Myeloma Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Multiple Myeloma Treatment Market Share by Type (2016-2027)
Figure 23. North America Multiple Myeloma Treatment Market Share by Application (2016-2027)
Figure 24. North America Multiple Myeloma Treatment Market Share by Country (2016-2027)
Figure 25. United States Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Multiple Myeloma Treatment Market Share by Type (2016-2027)
Figure 29. Europe Multiple Myeloma Treatment Market Share by Application (2016-2027)
Figure 30. Europe Multiple Myeloma Treatment Market Share by Country (2016-2027)
Figure 31. Germany Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Multiple Myeloma Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Multiple Myeloma Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Multiple Myeloma Treatment Market Share by Region (2016-2027)
Figure 41. China Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Multiple Myeloma Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Multiple Myeloma Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Multiple Myeloma Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Multiple Myeloma Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Multiple Myeloma Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Multiple Myeloma Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Multiple Myeloma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Johnson & Johnson Revenue Growth Rate in Multiple Myeloma Treatment Business (2016-2021)
Figure 61. Roche Holding Revenue Growth Rate in Multiple Myeloma Treatment Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Multiple Myeloma Treatment Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Multiple Myeloma Treatment Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Multiple Myeloma Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年）

Global Multiple Myeloma Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3953 2021年4月 96Pages
QYResearch社発行の本調査資料では、多発性骨髄腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法・その他薬剤、放射線、幹細胞移植、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年）

Global CAR T-Cell Therapy for Multiple Myeloma Market Size, Status and Forecast 2021-2027
QYR2104Z1099 2021年4月 94Pages
QYResearch社発行の本調査資料では、多発性骨髄腫用CART細胞療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（多発性骨髄腫、難治性/再発性多発性骨髄腫）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年）

世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3956 2021年4月 93Pages
QYResearch社発行の本調査資料では、多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫調節剤、免疫抑制剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の多発性内分泌腺腫症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Endocrine Neoplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3952 2021年4月 97Pages
QYResearch社発行の本調査資料では、多発性内分泌腺腫症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の進行性再発性多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Progressive Relapsing Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4818 2021年4月 99Pages
QYResearch社発行の本調査資料では、進行性再発性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）、用途別市場規模（診療所、病院、その他）、主要...

世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Primary Progressive Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4790 2021年4月 94Pages
QYResearch社発行の本調査資料では、一次進行性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、ラキニモドナトリウム、その他）、用途別市場規模（病院、診療所、...

世界のマッシブマイモ（多入力・多出力）市場規模・現状・予測（2021年-2027年）

Global Massive MIMO(Multiple-input multiple-output) Market Size, Status and Forecast 2021-2027
QYR2104Z3584 2021年4月 133Pages
QYResearch社発行の本調査資料では、マッシブマイモ（多入力・多出力）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（LTE-高度、LTE-高度プロ、5G）、用途別市場規模（通信、軍事、その他）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Stem Cell Therapy for Multiple Sclerosis Market Size, Status and Forecast 2021-2027
QYR2104Z5441 2021年4月 90Pages
QYResearch社発行の本調査資料では、多発性硬化症幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、脳室内）、用途別市場規模（再発寛解型多発性硬化症（RRMS）、一次進行型多発性硬化症（PPMS）、二次性進行型多発性硬化症...

世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年）

世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年） Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma i…
世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and somet…
世界の多発性内分泌腺腫症治療市場規模・現状・予測（2021年-2027年） Multiple Endocrine Neoplasia is a disease caused by genetic mutation. Multiple Endocrine Neoplasia is inherited from one generation to another generation. The symptoms of the multiple endocrine neoplasia depends on the type of gland which is affected by the disease. The multiple endocrine neoplasia …